Search research articles
Contact Us
Filters
Showing results (311-320 of 329) with videos related to
Page
of 33
Sort By:
Antimicrobial Agents and Chemotherapy
|
November 11, 2009
Factors associated with virological response to etravirine in nonnucleoside reverse transcriptase inhibitor-experienced HIV-1-infected patients
Anne-Genevieve Marcelin, Philippe Flandre, Diane Descamps, et al.
Plos One
|
November 20, 2020
Performance of serum apolipoprotein-A1 as a sentinel of Covid-19
Thierry Poynard, Olivier Deckmyn, Marika Rudler, et al.
The Journal of Antimicrobial Chemotherapy
|
January 18, 2018
Phenotypic analysis of HIV-1 E157Q integrase polymorphism and impact on virological outcome in patients initiating an integrase inhibitor-based regimen
Charlotte Charpentier, Isabelle Malet, Elisabeth Andre-Garnier, et al.
International Journal of Antimicrobial Agents
|
April 9, 2013
A cohort study of treatment-experienced HIV-1-infected patients treated with raltegravir: factors associated with virological response and mutations selected at failure
Anne-Geneviève Marcelin, Constance Delaugerre, Céline Beaudoux, et al.
Antimicrobial Agents and Chemotherapy
|
April 28, 2005
Virological and pharmacological parameters predicting the response to lopinavir-ritonavir in heavily protease inhibitor-experienced patients
Anne-Geneviève Marcelin, Isabelle Cohen-Codar, Martin S King, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
October 3, 2019
New HIV-1 circulating recombinant form 94: from phylogenetic detection of a large transmission cluster to prevention in the age of geosocial-networking apps in France, 2013 to 2017
Marc Wirden, Fabienne De Oliveira, Magali Bouvier-Alias, et al.
The Journal of Antimicrobial Chemotherapy
|
June 27, 2013
National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011
Diane Descamps, Lambert Assoumou, Marie-Laure Chaix, et al.
The Journal of Antimicrobial Chemotherapy
|
October 27, 2014
Antiretroviral-naive and -treated HIV-1 patients can harbour more resistant viruses in CSF than in plasma
Cathia Soulie, Diane Descamps, Maxime Grudé, et al.
The Journal of Antimicrobial Chemotherapy
|
February 22, 2019
Resistance to integrase inhibitors: a national study in HIV-1-infected treatment-naive and -experienced patients
Anne-Genevieve Marcelin, Maxime Grude, Charlotte Charpentier, et al.
Antimicrobial Agents and Chemotherapy
|
June 10, 2026
A French national observatory of people with HIV initiating lenacapavir-based treatment after regulatory approval
Charlotte Charpentier, Thomas Montrouge, Marc Wirden, et al.
Page
of 33
Search research articles
Search
Showing results (311-320 of 329) with videos related to
Sort By:
Page
of 33
Antimicrobial Agents and Chemotherapy
|
November 11, 2009
Factors associated with virological response to etravirine in nonnucleoside reverse transcriptase inhibitor-experienced HIV-1-infected patients
Anne-Genevieve Marcelin, Philippe Flandre, Diane Descamps, et al.
Plos One
|
November 20, 2020
Performance of serum apolipoprotein-A1 as a sentinel of Covid-19
Thierry Poynard, Olivier Deckmyn, Marika Rudler, et al.
The Journal of Antimicrobial Chemotherapy
|
January 18, 2018
Phenotypic analysis of HIV-1 E157Q integrase polymorphism and impact on virological outcome in patients initiating an integrase inhibitor-based regimen
Charlotte Charpentier, Isabelle Malet, Elisabeth Andre-Garnier, et al.
International Journal of Antimicrobial Agents
|
April 9, 2013
A cohort study of treatment-experienced HIV-1-infected patients treated with raltegravir: factors associated with virological response and mutations selected at failure
Anne-Geneviève Marcelin, Constance Delaugerre, Céline Beaudoux, et al.
Antimicrobial Agents and Chemotherapy
|
April 28, 2005
Virological and pharmacological parameters predicting the response to lopinavir-ritonavir in heavily protease inhibitor-experienced patients
Anne-Geneviève Marcelin, Isabelle Cohen-Codar, Martin S King, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
October 3, 2019
New HIV-1 circulating recombinant form 94: from phylogenetic detection of a large transmission cluster to prevention in the age of geosocial-networking apps in France, 2013 to 2017
Marc Wirden, Fabienne De Oliveira, Magali Bouvier-Alias, et al.
The Journal of Antimicrobial Chemotherapy
|
June 27, 2013
National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011
Diane Descamps, Lambert Assoumou, Marie-Laure Chaix, et al.
The Journal of Antimicrobial Chemotherapy
|
October 27, 2014
Antiretroviral-naive and -treated HIV-1 patients can harbour more resistant viruses in CSF than in plasma
Cathia Soulie, Diane Descamps, Maxime Grudé, et al.
The Journal of Antimicrobial Chemotherapy
|
February 22, 2019
Resistance to integrase inhibitors: a national study in HIV-1-infected treatment-naive and -experienced patients
Anne-Genevieve Marcelin, Maxime Grude, Charlotte Charpentier, et al.
Antimicrobial Agents and Chemotherapy
|
June 10, 2026
A French national observatory of people with HIV initiating lenacapavir-based treatment after regulatory approval
Charlotte Charpentier, Thomas Montrouge, Marc Wirden, et al.
Page
of 33